Clinical trial · Observational
Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of Incident WHO II and III Grade Gliomas.
Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of WHO II and III Grade Incident Gliomas.
NCT04461002CI-TRIAL-00078513completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
From the medical records of a series of patients operated on for incident grade II and III glioma, the primary objective is to evaluate the correlation between the molecular profile of tumours and preoperative imaging data (by FDG and FDOPA PET-scan and multimodal MRI).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Glioma | Glioma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Retrospective analysis | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Cohort
- description
- Retrospective cohort
- interventionNames
- Other: Retrospective analysis
Primary outcomes (1)
- measure
- Primary outcome
- timeFrame
- 4 years
- description
- Evaluate the correlation between tumour molecular profile and preoperative imaging data (FDG and FDOPA PET-scan and multimodal MRI).
Secondary outcomes (2)
- measure
- Molecular profile
- timeFrame
- 4years
- description
- Evaluate the overall survival and progression-free survival of patients based on the molecular profile of gliomas.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Subject 18 years of age or older, having been informed of the research * Subject operated on with an incident glioma of grade II or III, histologically confirmed (WHO 2016 classification) * Subject for which all preoperative imaging data is available (MRI, FDG and FDOPA PET-scan) * Subject for which molecular data of the lesion are available Exclusion Criteria: * Subject having signified his opposition to the use of his medical data * Subject under safeguard of justice, guardianship or trusteeship * Subject with incomplete or missing part of the molecular and/or imaging data
References
Publications (0)
Data not yet available
No reference posted for this study.